Formel

Quick links to important sections

Formel

Method of action: Antitussive

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Formel

Property Description
Active Ingredients Dextromethorphan Hydrobromide, Guaifenesin
Form Syrup, Liquid drops, Tablets, Capsules
Pharmacological Class Antitussive (Cough Suppressant) and Expectorant
Common Use Temporary relief of cough and chest congestion
Origin Synthetic organic compounds

What Type of Medicine is Formel and What is its Purpose?

Formel is defined as a specific combination medication containing two distinct active ingredients: Dextromethorphan Hydrobromide and Guaifenesin. This formulation is globally recognized for its dual-action approach and is classified pharmacologically as both an Antitussive (cough suppressant) and an Expectorant. Formel is primarily formulated for the temporary relief of symptoms involving both coughing and mucus congestion, a clinical need commonly addressed by such combinations. Unlike single-agent products, Formel is specifically designed as an Over-the-counter (OTC) medicine to simultaneously manage the irritation of a persistent cough and the discomfort of accumulated mucus.


What are the Active Ingredients in Formel?

Formel’s core composition relies on the specific actions of its two components: Dextromethorphan Hydrobromide and Guaifenesin. Both are defined as synthetic organic compounds. Dextromethorphan Hydrobromide functions to reduce the impulse to cough by acting on the central nervous system, a mechanism clinically recognized for its effectiveness in controlling cough frequency. Concurrently, Guaifenesin works to loosen and thin tenacious secretions in the airways. This complementary pairing ensures that the medicine addresses the overall congestion and cough cycle, which differentiates it from medications addressing only one symptom. For example, a typical use scenario involves relief when a cold shifts from a dry, irritating cough to a chest cough with mucus.


What are the Available Forms of Formel?

Formel is prepared for Oral administration and is accessible in multiple dosage form(s) to meet various patient needs. These formulations commonly include aqueous or hydroalcoholic preparations like Syrup and concentrated Liquid drops, as well as solid forms such as standard or extended-release Tablets and Capsules. A distinguishing feature of certain Formel presentations is the availability of specific flavors or non-drowsy formulations, which broadens its applicability across different user needs. The fundamental dual action of the active ingredients, however, remains consistent across all forms designed for Oral administration.

What side effects are possible with Formel?

Possible Side Effects and Safety Information

The official safety documentation for Formel (Dextromethorphan Hydrobromide and Guaifenesin) organizes potential adverse effects by both frequency and the physiological system affected, adhering to regulatory standards.


Adverse Reaction Scope

Category Description
Key adverse reaction categories Gastrointestinal disturbances, Nervous system effects, Skin and hypersensitivity reactions.
Frequency classification Common: Nausea, Vomiting, Dizziness, Drowsiness, Headache, Gastrointestinal discomfort. Less Common/Rare: Nervousness, Insomnia, Skin Rash, Urticaria.
System-organ classes involved Gastrointestinal disorders, Nervous system disorders, Skin and Subcutaneous Tissue Disorders, Immune System Disorders.
Serious adverse reactions Serotonin Syndrome (a serious, documented risk when co-administered with certain other medications, such as MAOIs), Severe Allergic Reactions (including Angioedema).

Safety Constraints and Considerations

Official regulatory documents detail specific constraints related to the medicine's use:

  • Known Hypersensitivity: The medicine is restricted in individuals with a documented history of hypersensitivity to the active ingredients.
  • Co-administration Restriction: Use is strictly restricted within 14 days of stopping a Monoamine Oxidase Inhibitor (MAOI) due to the documented risk of Serotonin Syndrome.
  • Population Considerations: Caution or restriction is advised for the pediatric population regarding potential central nervous system effects, and for patients with severe hepatic impairment due to altered metabolism.
  • Exposure Patterns: Adverse effects are generally observed during or shortly after the start of treatment and are not typically associated with chronic, long-term use.

These constraints define the high-level safety profile, ensuring that the clinically important risks, though rare, are clearly communicated alongside the more common, expected effects.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Formel

Documented Overdose Presentations: Overdose involving Formel (Dextromethorphan Hydrobromide/Guaifenesin) may result in significant Central Nervous System (CNS) effects. Documented manifestations include somnolence, confusion, agitation, dizziness, ataxia (loss of coordination), and nystagmus (involuntary eye movements). Systemic signs such as tachycardia (rapid heart rate), hypertension, and hyperthermia (high body temperature) have also been recorded in overdose situations, alongside severe nausea and vomiting.

Life-Threatening Outcomes: Severe overdose is classified by regulatory authorities as potentially life-threatening due to the risks of respiratory depression, seizures, and coma. The complication of Serotonin Syndrome is specifically documented, particularly when the product is co-ingested with other serotonergic medicines, necessitating urgent intervention.

Required Emergency Action: The official guidance is to seek immediate medical attention or call emergency services right away if overdose is suspected or confirmed. Urgent medical care is required when the individual experiences difficulty breathing, has a seizure, or becomes unresponsive. Treatment in a healthcare setting is primarily supportive and symptomatic, and may involve procedures such as the use of activated charcoal, benzodiazepines for severe agitation, or naloxone for profound CNS or respiratory depression.

Therapeutic Uses of Formel

What Formel Treats: Main Uses and Benefits

Formel (used here as a placeholder for prescription medications with established therapeutic profiles) is applied across domains where additional symptomatic support is needed, particularly for conditions involving episodic or fluctuating manifestations of discomfort. For example, drugs in this therapeutic class are commonly used to help with conditions presenting with systemic or localized discomfort, such as symptoms that create noticeable physiological strain.

Formel is commonly used across conditions presenting with acute episodes and is relevant for managing symptoms that interfere with daily comfort. Its application may assist with easing the overall symptom burden by providing supportive relief when symptoms intensify and supportive relief is needed. This action contributes to easing the overall symptom load and supports the patient during difficult episodes by easing distress.

Quick Fact: Support for Episodic Symptoms

The product is considered relevant in clinical settings that involve acute or unstable symptom patterns, supporting general well-being during symptomatic phases. This supportive relief may be part of symptomatic management for symptoms related to physical discomfort, systemic imbalance, or heightened physiological activity.

“Helps maintain a sense of stability when symptoms are more noticeable and supports patients during episodes of heightened discomfort.”

Regulatory References

  1. NIH StatPearls overview on Buprenorphine

Eligibility and Restrictions for Use

Official Eligibility and Restriction Rules

Formel (Dextromethorphan/Guaifenesin combination) eligibility is strictly defined by regulatory labeling based on age, concurrent medications, and pre-existing health conditions.

Category Official Regulatory Statement
Populations Allowed Adults and Children 12 years of age and over are permitted to use the medicine under standard labeled conditions.
Absolute Contraindications Use is prohibited for individuals taking a Monoamine Oxidase Inhibitor (MAOI) or within 14 days of stopping one. Use is also contraindicated in patients with known hypersensitivity to any product ingredient.
Age-Related Restrictions Children under 4 years of age are contraindicated for use. Use in children under 12 years of age is not recommended in many jurisdictions and is restricted to professional consultation.
Conditional Restrictions Pregnancy and Breastfeeding: Use is generally not recommended; consultation with a health professional is advised as safety is not fully established in these populations.
Comorbidity: Individuals with severe liver or kidney disease or chronic respiratory conditions (like asthma or COPD) should only use the medicine with professional guidance.

Eligibility Severity Classification

Classification Official Regulatory Wording (Examples)
Prohibited Status Do not use; Contraindicated
Restricted Status Ask a doctor before use; Not recommended

Regulatory documents establish clear boundaries for Formel eligibility by classifying user groups into absolute prohibitions and conditional restrictions, primarily based on the risk of serious interaction (MAOIs) or limited safety data (pediatrics, pregnancy).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations and Timing Rules

The regulatory profile for Formel establishes a formal contraindication with Monoamine Oxidase Inhibitors (MAOIs) due to the high, documented risk of Serotonin Syndrome. This restriction is absolute and requires a mandatory separation period: administration must not occur until at least 14 days have passed after discontinuing MAOI therapy.


Pharmacokinetic and Pharmacodynamic Constraints

Formel’s interaction profile is structured around its metabolism through the Cytochrome P450 2D6 (CYP2D6) enzyme system. Co-administration with strong CYP2D6 inhibitors is officially documented to interfere with this clearance pathway, resulting in reduced clearance and an increased systemic plasma concentration of Dextromethorphan.

A major pharmacodynamic interaction is noted with other serotonergic agents, including certain antidepressants (e.g., SSRIs and SNRIs) and the herbal product St. John’s Wort. Co-administration with these agents increases the documented potential for an additive effect leading to Serotonin Syndrome. Furthermore, the combination of Formel with Alcohol or other CNS depressants is officially noted to cause additive CNS depression, increasing risks such as dizziness and drowsiness.


Population-Specific Considerations

Regulatory documents also include notes for specific populations where systemic exposure may be heightened. Caution is formally noted for patients with hepatic impairment, as their condition may result in a reduced clearance of Dextromethorphan, leading to increased systemic exposure.

Mechanism of Action

How Formel works

The mechanism of Formel involves a dual-domain action, modulating both central and peripheral physiological systems. The first component operates on the Central Nervous System (CNS), primarily acting as a low-affinity antagonist at the NMDA receptor and an agonist at the Sigma-1 (sigma1) receptor within the brainstem's cough center. This molecular interaction modulates the central cough reflex pathway, resulting in a physiological elevation of the threshold required for afferent signals to trigger a motor response.

The second component utilizes a neurogenic reflex initiated by localized stimulation of vagal afferent nerves in the gastric mucosa. This peripheral cascade triggers a parasympathetic efferent signal to the airway secretory glands, promoting an increase in the volume and a crucial reduction in the viscosity of tracheobronchial secretions. This physiological change supports the mucociliary transport system, promoting the mobilization of material from the airways.

The combined mechanism employs a complementary approach, where the central suppression of the neurological impulse acts concurrently with the peripheral modulation of airway secretion properties. This simultaneous dampening of the central drive and alteration of peripheral secretions affects the overall physiological state by modulating the sensitivity of the cough reflex and supporting clearance.

Dosage and Administration Information

How to Use Formel

The usage protocol for Formel (Dextromethorphan Hydrobromide and Guaifenesin) is defined by its approved administration route, standardized dosing schedules, and specific intake requirements.


Official Administration Guidelines

Formel is available in multiple forms, including liquids, syrups, and oral tablets or capsules, with all formulations approved solely for Oral administration. The specific frequency of use is governed by the product type:

Product Type Frequency Maximum Daily Limit (Dextromethorphan)
Immediate-Release (IR) Every 4 hours (up to 6 doses/24 hours) 120 mg
Extended-Release (ER) Every 12 hours (twice daily) Based on specific fixed dose

Standard adult (12 years and older) dosing for immediate-release preparations typically ranges from 10 mg to 20 mg of Dextromethorphan and 200 mg to 400 mg of Guaifenesin per dose, with a maximum of 2400 mg of Guaifenesin in 24 hours.


Procedural Conditions and Duration of Use

Formel may be administered without regard to the timing of meals. Proper intake requires specific actions depending on the formulation. Liquid forms must be shaken well and measured using the provided dosing cup for accuracy. Solid forms should be taken with a full glass of water. A critical instruction for Extended-Release tablets is that they must not be crushed, chewed, or broken, as this compromises the intended release pattern. The medicine is intended for temporary relief only. It is specified that use should not continue for a cough that persists or recurs after 7 days.

Recent Clinical Evidence

Research evidence / Overview of Studies for Formel

Evidence for Temporary Relief of Acute Cough

Research exploring acute cough symptoms is primarily relevant in trials assessing short-term or episodic symptom patterns. These studies, mostly conducted as Randomized Controlled Trials (RCTs), focused on the antitussive component (Dextromethorphan). Researchers examined patient-reported experiences and outcomes related to episodic or acute changes in cough frequency and intensity, primarily in adults with cough associated with common respiratory infections.

The findings related to these outcomes were reported to be mixed and varied across studies by systematic reviews. Research highlights changes measured during the study period, but the evidence quality varies. For certain groups, such as very young children, regulatory restrictions exist due to safety concerns and inconsistent efficacy evidence.

Evidence for Temporary Relief of Chest Congestion and Mucus

The second main focus of the research involves the expectorant component (Guaifenesin). Studies, including RCTs and systematic reviews, monitored patient-reported outcomes describing perceived discomfort and evaluated changes related to sputum viscosity (thickness) and subjective measures of the ease of expectoration.

Reviews indicate that demonstrating clinically significant and consistent symptom relief for the treatment of acute congestion was observed in some studies but was mixed overall. Some trials described patterns where patients noted an increase in the patient-reported ease of clearing secretions. Certainty remains low regarding the consistent clinical benefit across all individuals.

What Research Gaps and Uncertainty Remain

The evidence primarily applies to the populations studied during the acute phase, as follow-up durations were limited. Long-term effects are not fully established.

The overall certainty remains low due to the volume of studies where findings were mixed, particularly when assessing whether the combination contributes additional observed effects beyond using a single ingredient alone. Comparative evidence is lacking to definitively show differences between the fixed-dose combination and alternative treatment options. Research provides limited insight into use in older adults and pregnant or nursing individuals.

Key Studies & References

  1. Summary of the evidence | Cough (acute): antimicrobial prescribing | Guidance - NICE (NG120)
  2. Dextromethorphan Guaifenesin - StatPearls - NCBI Bookshelf (NIH)

Frequently Asked Questions (FAQ)

Common questions about Formel (FAQ)


Q: Does Formel work right away, or does it take time to notice effects?

A: Information for the expectorant component (Guaifenesin) often notes the onset of action may occur around 30 minutes following oral administration. The antitussive component (Dextromethorphan) is primarily defined by its purpose of providing temporary relief from the urge to cough.


Q: Is it common to feel tired when starting Formel?

A: Official safety documents list both drowsiness and dizziness among the more common side effects users may experience. These effects are generally noted to occur during or shortly after the start of treatment. Because of these potential effects, regulatory information advises caution regarding activities that require full mental alertness.


Q: Are there any specific foods I should avoid while on Formel?

A: Official drug information states that Formel may be administered without regard to the timing of meals. Clinical studies have also indicated that a high-fat and high-caloric meal did not significantly change how the medicine's active components were absorbed by the body. The regulatory labeling does not formally restrict specific foods.


Q: Does Formel have a risk of dependence or addiction?

A: The active ingredient Dextromethorphan is globally subject to official warnings regarding potential for misuse and abuse, which can result in serious complications. When used at authorized doses, the drug is not generally associated with the issues noted with misuse.


Q: Is Formel the same as the generic version?

A: Formel is a brand name product that contains the generic active ingredients Dextromethorphan Hydrobromide and Guaifenesin. These generic components are the standardized, chemical names for the medicines and are found in various over-the-counter (OTC) products.


Q: Is Formel safe for people with kidney problems (as described in official sources)?

A: Official regulatory documentation notes that individuals with severe kidney disease should only use the medicine with professional guidance. This conditional restriction is noted in the eligibility rules provided in the product's official labeling.


Q: Do I need to take Formel with food?

A: Official administration guidelines state that Formel may be taken without regard to the timing of meals. However, certain formulations, such as solid forms like tablets or capsules, should generally be taken with a full glass of water, as instructed in the usage guidelines.


Q: Can Formel affect my ability to drive?

A: Because the official product information lists dizziness and drowsiness as common side effects, patients are generally advised to understand how the medicine affects them. Regulatory information advises caution regarding activities that require full mental alertness, such as driving or operating machinery, due to the potential for these side effects.


Q: Is it possible to be allergic to Formel?

A: The medicine is formally contraindicated (prohibited) for use in individuals with a documented history of known hypersensitivity to any of its active or inactive ingredients. Severe allergic reactions, including angioedema, are also noted as a serious, though rare, adverse reaction in the official safety profile.


Q: Is Formel suitable for children or adolescents?

A: Official regulatory documents define the allowed population as adults and children 12 years of age and over. Use in children under 12 years of age is generally not recommended or is restricted to professional consultation, and is specifically prohibited for children under 4 years of age.


Q: Are the side effects of Formel temporary?

A: Official documentation notes that adverse effects are typically observed during or shortly after the start of treatment. They are generally not associated with chronic, long-term use, which aligns with the drug's intended use for temporary symptom relief.


Q: How does Formel affect sleep patterns?

A: The official product label indicates the antitussive component is included to suppress the impulse to cough, a factor that may support getting to sleep. Conversely, side effects listed in the safety information include both insomnia (trouble sleeping) and drowsiness.


Q: Is Formel available in liquid form?

A: Yes, Formel is prepared for oral administration and is accessible in multiple forms. These formulations commonly include aqueous preparations like Syrup and concentrated Liquid drops, in addition to solid forms such as tablets and capsules.


Q: Does Formel affect mood or emotion?

A: Side effects categorized as nervous system disorders include nervousness. Furthermore, serious, though rare, adverse reactions linked to other serotonergic agents, such as Serotonin Syndrome, can involve changes in a person's mood and mental status.


Q: What should I know about Formel before I start taking it?

A: Official regulatory information typically summarizes the key facts, which include the active ingredients, intended purpose, administration guidelines, possible side effects, and specific contraindications (such as avoiding use with MAOIs). These details define the product's official parameters for use.


Q: If Formel is not working for me, what should I generally expect the next step to be?

A: Official labeling specifies that use should not continue for a cough that persists or recurs after 7 days. The documentation also advises seeking professional guidance if the cough is accompanied by a fever, rash, or persistent headache.


How should Formel be stored and disposed of?

Storage and Disposal Requirements for Formel

Formel (Dextromethorphan Hydrobromide and Guaifenesin) must be stored and handled according to the official specifications provided in its regulatory labeling.

Storage Conditions

Requirement Official Statement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F).
Protection Protect from excessive heat, direct light, and moisture. Do not freeze liquid formulations.
Packaging Keep the product in the original container and maintain it tightly closed.
Safety Store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Formel should be disposed of via a drug take-back program if one is available in the community. If not, follow general regulatory guidelines for household disposal: the medicine must be mixed with an unappealing substance like dirt or coffee grounds, sealed in a container, and placed in the trash. The container's identifying information should be removed before disposal. Do not flush this product down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Formel found in:

A-Z Index: